Business Context and Reporting Period
Company: Lifecore Biomedical, Inc. (LFCR)
Filing Type: Form 8-K (Current Report)
Report Date: August 31, 2023
Context: The filing announces the issuance of a press release containing consolidated financial results for the fourth quarter and full year of fiscal 2023, which ended on May 28, 2023.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being contained within the press release furnished as Exhibit 99.1, which is not included in the input text.
Material Changes
The filing text does not provide specific details regarding material changes versus prior periods. It solely serves to notify the market of the release of the fiscal 2023 results.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release (Exhibit 99.1) for management commentary but does not include the text of that commentary.
Legal Disclaimer: The information in Item 2.02 and Exhibit 99.1 is furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. It is not subject to the liabilities of that Section and will not be incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review the full text of the press release (Exhibit 99.1) to obtain specific revenue, earnings, and cash flow figures for Q4 and full-year fiscal 2023.
- Verify the fiscal year-end date of May 28, 2023, when comparing results to prior periods.
- Confirm whether the furnished information has been incorporated by reference in subsequent filings if relying on it for legal purposes.